Immune reconstitution during bone marrow transplantation has been proposed to produce a fetal-type immune system. This characteristic may contribute to the relative immunodeficiency that occurs in the early post-transplant period. This review reappraises recent studies of immunoglobulin heavy chain genes produced by the recovering immune system. Comparison of these genes to those that are generated by fetal and adult B cells, demonstrates that there is no evidence to support the conclusion that adult lymphocytes in the graft reverse to a fetal stage of differentiation. In terms of lymphocyte diversity, the inadequacy of the recovering immune system is more likely to be explained by a combination of other factors -such as the delayed occurrence of somatic hypermutation and class switching, and clonal dominance. Keywords: immune reconstitution; immunoglobulin; repertoire development; CDR3; diversity; fetus The purpose of stemcell/bone marrow transplantation (BMT) is transfer of a functional immune system to an immunocompromised recipient. The early period after BMT, however, is characterized by cellular and humoral immunodeficiency which can last for months to years. Whereas components of non-specific immunity (granulocytes, monocytes/macrophages and NK cells) recover within 2-6 months, functional recovery of B and T lymphocytes can take up to 2 years or longer.
The purpose of stemcell/bone marrow transplantation (BMT) is transfer of a functional immune system to an immunocompromised recipient. The early period after BMT, however, is characterized by cellular and humoral immunodeficiency which can last for months to years. Whereas components of non-specific immunity (granulocytes, monocytes/macrophages and NK cells) recover within 2-6 months, functional recovery of B and T lymphocytes can take up to 2 years or longer. 1 Many factors contributing to this slow recovery have been identified, such as the immunosuppressive effect of high-dose radio/chemotherapy, the effect of graft-versus-host disease (GVHD), treatment of GVHD by immunosuppressants and decreased thymic function in older patients.
Serological studies and analysis of cell surface marker expression showed that reconstitution of humoral immunocompetence follows patterns previously described in neonates. [2] [3] [4] [5] [6] Antibodies against protein and conjugated polysaccharide antigens predate immune responses against carbo- hydrate antigens. [7] [8] [9] [10] [11] [12] Furthermore, appearance of immunoglobulin (Ig) subclasses in BMT patients reflects serological patterns identified in newborns, with IgM levels produced first and normalizing within 2-6 months, followed by normal IgG levels within 3-18 months and IgA levels within 6-36 months. 3, 4, [13] [14] [15] [16] Finally, the first B cells to be generated after transplant phenotypically resemble cord blood lymphocytes and frequently express the CD5 and CD38 markers. 3, 4, [17] [18] [19] These observations are commonly explained as an indication that BMT immune-reconstitution recapitulates a program that is particular to the newborn immune system.
Recapitulation of fetal ontogeny as a mechanism of immune reconstitution in BMT
A molecular biological approach to analysis of the reconstituting immune system has become increasingly popular in recent years. Contrary to serological findings, the DNA sequence of IgH chains generated after BMT was interpreted as an indication that BMT immune reconstitution follows a developmental program used by fetal B cells to build their immune repertoire. [20] [21] [22] Although this conclusion is controversial, it has important implications for our understanding of post-BMT immunity because the fetal immune system is very different from that of newborns and adults. This is best illustrated by the lower diversity of antigenbinding sites expressed by fetal B and T cell receptors (see below). A fetal-like post-transplant repertoire -of diminished diversity -could contribute to the relative immunodeficiency of the transplant recipient. In addition, the fetal immune system contains a high frequency of low-affinity self-reactive antibodies. 23, 24 This may be associated with particular three-dimensional characteristics of fetal antigen receptors, 25 or the abundance of CD5 + B cells in fetal tissue (which are associated with formation of polyreactive autoantibodies). 26, 27 The possibility that 'fetal-type' antigen receptors are common post BMT, in conjunction with an abundance of CD5 + B cells in the early post-transplant period, could explain self-reactive specificities occurring at this stage. [28] [29] [30] [31] [32] [33] A fetal program of immune reconstitution is difficult to reconcile with neonatal characteristics of the post-transplant immune system, however, because B cells in newborns generate highly diverse -'adult-like' -antigen receptors. [34] [35] [36] In addition, precursor B cells in adult bone marrow exhibit none of the characteristics that typify the fetal immune sytem. 37 The conclusion that post-BMT immune repertoires exhibit fetal characteristics therefore suggests that precursor lymphocytes in the graft return to a fetal stage. This disagrees with earlier studies, particularly in mice, which demonstrated that fetal and adult lymphoid precursors are distinct in terms of morphological characteristics, expression of surface markers and TdT, and antigen receptor diversity. [38] [39] [40] These characteristics appear to be fixed. For instance, fetal B cells propagated on an adult bone marrow stromal layer retained their fetal characteristics and did not develop into an adult-like population. 41 Similarly, repopulation of mouse fetal thymic lobes with T cell precursors (isolated from fetal liver or adult BM) demonstrated that the progenitor source determines whether the immune repertoire is fetal-like or not. 42 It is therefore difficult to envisage that precursor lymphocytes in an adult graft undergo a fetal program of development when placed in the micro-environment of an adult BMT recipient. Clarification of this issue is important for our conceptual understanding of the kinetics of BMT immune reconstitution and the relative immunodeficiency that occurs in transplant patients. This review reappraises conclusions of molecular analysis of post-BMT IgH chain genes, in the context of current knowledge of human fetal immunity and new findings in transplant patients. While discussing the current literature in the context of fetal-or adult-like characteristics of the developing immune system, we should ask ourselves two questions: how do we define a fetal Ig repertoire, and to what extent is this reflected during immune-reconstitution after BMT?
V H gene expression patterns as a developmental marker
Our understanding of human fetal repertoire development is guided by patterns identified in the mouse. While assembling Ig heavy (H) chain genes from variable (V H ), diversity (D H ) and joining (J H ) segments, mouse fetal B cells primarily employ V H elements that lie 3′ in the H chain locus (closest to the J H elements). By contrast, B cells in adult animals express a more randomized V H repertoire that appears determined by the size of the V H family. The 'J H -proximity hypothesis' predicts that use of V H segments by fetal B cells is governed by their location in the H chain locus. 43 Is a similar pattern of V H usage established by human fetal B cells as well?
Expression of V H elements in human fetal tissue
Second trimester human B lymphocytes in fetal liver employ a limited number of V H elements. [44] [45] [46] The multimember V H 3 family contributes most frequently to the fetal repertoire, but two V H 3 elements (V3-23 (DP47/30p1) and V3-30.3 (DP46/56p1)) account for about 25% of the rearrangements. The V6-1 (V H 6/DP74) segment is estimated to be used by 5-15% of the IgH chain recombinations in fetal liver, which exceeds the usage frequency estimated on random usage. 44, 45, 47, 48 As V6-1 is the most J H -proximal V H element, this suggests that the human fetal V H repertoire supports the J H -proximity hypothesis.
This conclusion, however, is not supported by all studies. Resolution of the IgH chain locus DNA sequence showed that V H elements expressed at high frequencies in fetal liver do not necessarily cluster in a J H -proximal location. 49, 50 Our own studies with a V6-1-specific monoclonal antibody failed to detect a more frequent usage of V6-1 by fetal B cells than expected on the basis of random recombination. 51 In addition, the most frequently expressed V H segments in fetal liver (such as V3-23 and V3-30.3) are also employed at high frequencies in cord blood and adult peripheral blood. [52] [53] [54] [55] These findings collectively support the conclusion that the human fetal repertoire is not determined by physical proximity of V H segments to the J H elements. 21 analyzed the post-BMT repertoire using quantitative PCR, followed by V H -specific oligonucleotide hybridization. Five V H genes, frequently detected among fetal B cells, were studied: one V H 4 element (V4-59 (DP71/58p2)), three V H 3 elements (V3-30.3, V3-15 (DP38/20p1), and V3-13 (DP48/13-2)), and V6-1. B cells at 2-5 months post transplant employed these V H elements twice as frequently as B cells in controls, while the repertoire appeared only moderately restricted at 6 months post BMT. The conclusion of these two studies was that the early transplant period recapitulates fetal B cell development.
Studies reported by others, however, yielded conflicting findings. Suzuki and colleagues 56 reported that the Ig repertoire appears normalized as early as 90 days post transplant. The usage frequencies of V H 3 and V H 4 genes at 90 days and approximately 1 year after transplant were similar to those of healthy subjects, and overuse of the V3-23 and V4-34 (DP63) V H elements was seen in patients and controls alike.
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Clonal diversity of the post-transplant repertoire
The discrepancies between V H analyses of BMT patients could originate from a different clonal composition of the various immune repertoires. This could also explain the preferred expression of particular V H genes that is observed after BMT. Interpretation of V H -repertoire studies should take into account that V H frequencies can be affected by inordinate contribution of B cell clones that express par-ticular V H elements. This is particularly true for the early period of immune reconstitution following BMT: by randomly sequencing V6-1 + rearrangements, Näsman and Lundkvist 22 demonstrated that the early post-transplant repertoire is characterized by low clonal variability and clonal dominance. This observation was later confirmed and extended by colony hybridization of V H 3 + rearrangements with B cell clone-specific (CDR3) probes. 59 A more global view of clonal diversity is provided by the CDR3 fingerprinting/spectratyping method. [60] [61] [62] Applied to the post-BMT repertoire, CDR3 fingerprinting demonstrated that (oligo)clonal expansions dominate early IgM and IgG repertoires. 63 However, while IgM repertoires normalized within 3 to 4 months, the IgG compartment remained restricted for up to 9 months or longer. In addition, the contribution of V6-1 to IgH chain CDR3 diversity was limited at all stages of the post-transplant period. This underscores the conclusion that overexpression of V6-1 detected in previous studies is not necessarily explained by more frequent recombination of this element. The molecular studies of repertoire diversity correlate well with earlier serological analyses that demonstrated a high frequency of homogenous Ig components (H-Ig) after BMT. 32, 64 These H-Ig are detectable as early as 3 weeks, and as late as 5 years, after transplantation.
In conclusion, V H repertoire analysis during BMT immune reconstitution cannot clarify whether the early post-BMT repertoire is generated following a fetal program. First of all, V H usage frequencies are poor developmental markers because fetal and adult V H repertoires are very similar. In addition, V H usage frequencies determined after BMT may not reflect actual recombination frequencies because (oligo)clonal expansions are frequent at this stage.
Composition of the antigen binding site as a developmental marker
Although fetal and adult B cells use a common mechanism of V(D)J recombination to assemble their antigen receptor genes, the resulting repertoire is distinct at different developmental stages. This is best illustrated by the composition of the antigen binding pocket. Antigen binding sites are composed of three loops, termed complementaritydetermining regions (CDRs). The third CDR, CDR3, contributes essential residues for antigen binding and interacts directly with the antigen. IgH chain CDR3s are formed during assembly of the antigen receptor gene. They consist of the diversity (D H ) element and the V H -D H and D H -J H junctions. These junctional regions can be extensively processed during gene assembly. Nucleotides may be removed by exonuclease, while extra nucleotides can be added by terminal-deoxynucleotidyl transferase (TdT). Since these processes are more or less random, CDR3 regions are highly variable with regard to size and sequence. In addition, CDR3 diversity is developmentally controlled.
Patterns of CDR3 junctional diversity characterize the developmental stage
Ig heavy chain genes assembled by fetal B lymphocytes differ from those in the adult at three levels: distribution of D H elements, size and frequency of N-regions, and general length of the CDR3 region. [44] [45] [46] [65] [66] [67] [68] [69] Up to 45% of the -chains in fetal liver use the J H -proximal DQ52 D H element, whereas this gene is rarely detected in B cells of adults. This particular expression pattern is the only convincing example of repertoire skewing that supports the J Hproximity hypothesis in humans. An estimated 25% of first trimester Ig H chain genes lack N-regions, while N-segments in the remainder of the repertoire are shorter than those in adult B cells. Adult B cells rarely express Ig H chains that are totally devoid of N-regional diversity. 37, 52, 53, 65 The relative absence of N-regions in fetal heavy chain genes is most likely related to low level expression of TdT by fetal B cells. The preference for DQ52 (the shortest D H gene of all human D H elements), in combination with limited N-regional diversity, results in fetal CDR3 regions that are shorter and less diverse than their adult counterparts (Figure 1 ). For instance, the mean size of fetal IgH chain CDR3 regions is 10 amino acids, whereas the mean length of adult CDR3 regions is approximately 15 amino acids. The importance of this characteristic is underscored by the observation that smaller fetal CDR3 regions are also observed during T cell development 70, 71 and in species as diverse as mice, pigs and frogs. 72, 73 At birth, CDR3 regions appear as diverse as those in the adult. 25, 34, 35 Therefore, in determining whether the post-BMT repertoire resembles the fetal immune system, evaluation of CDR3 composition is a valuable and dependable tool. bone marrow. In addition, CDR3 segments constituting the early BMT repertoire contained extensive N-regional diversity at the V H -D H or D H -J H junctions, or both. The size distribution of these regions was very similar to that detected in adult peripheral blood and bone marrow B cells. 'Adult-type' D H usage patterns and distribution of Nregions produced a size-distribution of post-BMT CDR3 elements that fell within the adult range of IgH chain CDR3 sizes (Figure 1 ). This distribution was further supported by CDR3 fingerprinting results. 63 These data collectively show that the post-BMT immune repertoire is adult in nature.
Junctional diversity during immune reconstitution after BMT
Concluding remarks
The diversity of IgH chain genes generated after BMT supports the conclusion that immune reconstitution following transplantation does not follow a fetal pattern of B cell repertoire development. Around 3 months after transplantation, diversity of -chains appears as large as that observed in adult peripheral blood lymphocytes. From the earliest timepoints after transplantation and onwards, B cell receptor rearrangements show all hallmarks that are characteristic of B lymphocytes in adults. We can therefore conclude that the relative immunodeficiency that occurs in the first year after BMT is unlikely to result from formation of fetal-type IgH chain genes of limited diversity. Serological studies demonstrated that the early post-transplant repertoire has characteristics that typify the neonatal immune system, and molecular evidence does not suggest that precursor lymphocytes in the adult graft reverse to a fetal stage during engraftment. In terms of repertoire development, the period of relative immunodeficiency after BMT is most likely explained by a combination of factors including absence of somatic hypermutation, 56 delayed occurrence of classswitching, 63 and clonal dominance. 22, 59, 63 
